| An open label trial of anakinra to prevent respiratory failure in COVID-19 E Kyriazopoulou, P Panagopoulos, S Metallidis, GN Dalekos, G Poulakou, ... Elife 10, e66125, 2021 | 160 | 2021 |
| Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis E Kyriazopoulou, T Huet, G Cavalli, A Gori, M Kyprianou, P Pickkers, ... The Lancet Rheumatology 3 (10), e690-e697, 2021 | 143 | 2021 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 85 | 2021 |
| Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments G Kokkotis, K Kitsou, I Xynogalas, V Spoulou, G Magiorkinis, I Trontzas, ... Alimentary pharmacology & therapeutics 55 (2), 154-167, 2022 | 51 | 2022 |
| Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials E Panagiotou, G Gomatou, IP Trontzas, N Syrigos, E Kotteas Clinical and Translational Oncology 24 (2), 161-192, 2022 | 41 | 2022 |
| The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 32 | 2021 |
| Bcl-2 pathway inhibition in solid tumors: a review of clinical trials I Ploumaki, E Triantafyllou, IA Koumprentziotis, K Karampinos, ... Clinical and Translational Oncology 25 (6), 1554-1578, 2023 | 30 | 2023 |
| ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19 M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ... Scientific data 9 (1), 454, 2022 | 27 | 2022 |
| Beneficial effects of intermediate dosage of anticoagulation treatment on the prognosis of hospitalized COVID-19 patients: the ETHRA study G Poulakou, E Dimakakos, A Kollias, KG Kyriakoulis, V Rapti, I Trontzas, ... in vivo 35 (1), 653-661, 2021 | 27 | 2021 |
| Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors G Gomatou, I Trontzas, S Ioannou, M Drizou, N Syrigos, E Kotteas Molecular biology reports 48, 915-925, 2021 | 26 | 2021 |
| Malignant superior vena cava syndrome: state of the art V Patriarcheas, M Grammoustianou, N Ptohis, I Thanou, M Kostis, ... Cureus 14 (1), 2022 | 21 | 2022 |
| The effect of anakinra in hospitalized patients with COVID-19: an updated systematic review and meta-analysis KG Kyriakoulis, A Kollias, G Poulakou, IG Kyriakoulis, IP Trontzas, ... Journal of clinical medicine 10 (19), 4462, 2021 | 21 | 2021 |
| High versus standard intensity of thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis A Kollias, KG Kyriakoulis, IP Trontzas, V Rapti, IG Kyriakoulis, ... Journal of Clinical Medicine 10 (23), 5549, 2021 | 17 | 2021 |
| A Phase II study on the use of convalescent plasma for the treatment of severe COVID-19-a propensity score-matched control analysis V Pappa, A Bouchla, E Terpos, TP Thomopoulos, M Rosati, D Stellas, ... Microorganisms 9 (4), 806, 2021 | 15 | 2021 |
| BRAF/MEK inhibition in NSCLC: Mechanisms of resistance and how to overcome it I Tsamis, G Gomatou, SP Chachali, IP Trontzas, V Patriarcheas, ... Clinical and Translational Oncology 25 (1), 10-20, 2023 | 13 | 2023 |
| Comprehensive clinical evaluation of CAR-T cell immunotherapy for solid tumors: a path moving forward or a dead end? K Drougkas, K Karampinos, I Karavolias, IA Koumprentziotis, I Ploumaki, ... Journal of Cancer Research and Clinical Oncology 149 (6), 2709-2734, 2023 | 10 | 2023 |
| Vaccine-related autoimmune hepatitis: emerging association with SARS-CoV-2 vaccination or coincidence? IP Trontzas, KG Kyriakoulis, IA Vathiotis, A Syrigos, G Kounadis, ... Vaccines 10 (12), 2073, 2022 | 10 | 2022 |
| Pulmonary blastoma: a comprehensive overview of a rare entity I Tsamis, SP Chachali, G Gomatou, I Trontzas, M Mitsogianni, N Syrigos, ... Advances in Respiratory Medicine 89 (5), 511-519, 2021 | 9 | 2021 |
| Anakinra to prevent respiratory failure in COVID-19 E Kyriazopoulou, P Panagopoulos, S Metallidis, GN Dalekos, G Poulakou, ... medRxiv, 2020.10. 28.20217455, 2020 | 8 | 2020 |
| Assessment of seroconversion after SARS-CoV-2 vaccination in patients with lung cancer IP Trontzas, I Vathiotis, C Economidou, I Petridou, G Gomatou, ... Vaccines 10 (4), 618, 2022 | 7 | 2022 |
